These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17519429)

  • 1. Combining population health and baseline risk strategy by determining an age cutoff for initiating statins in patients with diabetes: a population-based study.
    Siyambalapitiya S; Bulugahapitiya U; Sithole J; Song S; Fernando DJ; Idris I
    Diabetes Care; 2007 Aug; 30(8):2025-9. PubMed ID: 17519429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between age and coronary heart disease (CHD) risk in Asian Indian patients with diabetes: A cross-sectional and prospective cohort study.
    Idris I; Deepa R; Fernando DJ; Mohan V
    Diabetes Res Clin Pract; 2008 Aug; 81(2):243-9. PubMed ID: 18495288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
    Ong HT
    QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001.
    Tonstad S; Rosvold EO; Furu K; Skurtveit S
    J Intern Med; 2004 Apr; 255(4):494-502. PubMed ID: 15049884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
    González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D;
    Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin prescription in men and women at cardiovascular risk: to whom and when?
    Brugts JJ; Deckers JW
    Curr Opin Cardiol; 2010 Sep; 25(5):484-9. PubMed ID: 20625281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study.
    Ferrara A; Mangione CM; Kim C; Marrero DG; Curb D; Stevens M; Selby JV;
    Diabetes Care; 2008 Jan; 31(1):69-74. PubMed ID: 17934157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term risk reduction: who needs treatment?
    Betteridge DJ
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl 2():S15-22. PubMed ID: 15885846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of lipid-lowering treatment according to lipid level.
    Pilote L; Ho V; Lavoie F; Coupal L; Zowall H; Grover SA
    Can J Cardiol; 2005 Jun; 21(8):681-7. PubMed ID: 16003451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the potential impact of population-wide and targeted high-risk blood pressure-lowering strategies on cardiovascular disease in China.
    Qin X; Jackson R; Marshall R; Lee L; Cao W; Zhan S; Hu Y
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):96-101. PubMed ID: 19237999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inertia or inaction? Blood pressure management and cardiovascular risk in diabetes.
    Owen AJ; Retegan C; Rockell M; Jennings G; Reid CM
    Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):643-7. PubMed ID: 19076166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
    Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
    Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of prevention on reducing the burden of cardiovascular disease.
    Kahn R; Robertson RM; Smith R; Eddy D
    Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT CVD-1).
    Bannink L; Wells S; Broad J; Riddell T; Jackson R
    N Z Med J; 2006 Nov; 119(1245):U2313. PubMed ID: 17146488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease.
    Emberson J; Whincup P; Morris R; Walker M; Ebrahim S
    Eur Heart J; 2004 Mar; 25(6):484-91. PubMed ID: 15039128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of cardiovascular risk factors in people with diabetes in primary care: cross-sectional study.
    Petri A; de Lusignan S; Williams J; Chan T; Majeed A
    Public Health; 2006 Jul; 120(7):654-63. PubMed ID: 16725165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study.
    Michos ED; Blumenthal RS
    J Am Coll Cardiol; 2009 Mar; 53(11):931-5. PubMed ID: 19281922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.